Norcada, established in 2001, is a Canadian pioneer in MEMS and Photonics technology, strategically located within one of North America's largest micro/nano technology clusters, Edmonton. This well-positioned enterprise harnesses state-of-the-art facilities to deliver specialized MEMS and Photonic products tailored for industrial and scientific applications. Notably, Norcada excels in producing ultra-thin membranes for electron and x-ray microscopy, sophisticated solutions for in-situ microscopy, x-ray optics, and innovative nanopore devices, pivotal for genomics and proteomics.
The company’s photonics offerings span near-infrared and mid-infrared DFB lasers ideal for spectroscopy, silicon optical bench devices catering to telecom, along with polarizers and gratings for Terahertz technologies. With its expansive international market reach, Norcada supports thousands of high-tech customers globally. Despite its strong position, the company has not yet disclosed any recent investment activities, indicating a potential opportunity for investors to engage with a robust player in the Biotechnology, Design, Manufacturing, and Semiconductor industries.